LNA Sante SA risk profile
39 Normal where most of the sector sits
Measured 21 October 2026 from LNA's filed statements. Recomputed nightly.
39 (Normal), driven by Leverage and coverage at 63, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 55 | Elevated | Stable | Drawdown from the 52-week high — 35.9% |
| Operating pressure | 41 | Elevated | Worsening | Costs outgrowing revenue — +0.2 percentage points |
| Cash conversion | 16 | Contained | Worsening | Capital spending against operating cash — 0.13x |
| Leverage and coverage | 63 | Stretched | Stable | Net debt to EBITDA — 5.28x |
| Competitive position | 37 | Normal | Stable | Revenue-growth gap against peers — -1.4 percentage points |
| Concentration | 31 | Normal | Stable | Geographic concentration — 2,487 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.